Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Cignarella

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Atherosclerosis|May 14, 2011
Targeting interleukin-1ß hampers atherosclerosis progression - is there great promise?Andrea Cignarella
Expert Opinion on Drug Discovery|March 14, 2013
Animal and cellular models for hypolipidemic drugsAndrea Cignarella
Current Atherosclerosis Reports|September 20, 2007
Increasingly selective pharmacologic targets in cardiovascular diseaseRodolfo Paoletti, Andrea Cignarella
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Mechanisms of estrogen protection in diabetes and metabolic diseaseAndrea Cignarella, Chiara Bolego
Current Atherosclerosis Reports|October 4, 2003
Can we stabilize unstable plaque?Rodolfo Paoletti, Andrea Cignarella
The Journal of Pharmacology and Experimental Therapeutics|July 12, 2025
FFAR1/GPR40 agonists: Are new players in type 2 diabetes management on the horizon?Andrea Cignarella, Samuel Tetteh-Quarshie
Cardiovascular & Hematological Agents in Medicinal Chemistry|June 2, 2010
Enhancing endothelial progenitor cell function through selective estrogen receptor modulation: a potential approach to cardiovascular risk reductionAndrea Cignarella, Gian Paolo Fadini
The Journal of Pharmacology and Experimental Therapeutics|July 18, 2024
Mechanistic Chronopharmacology: Preclinical Modeling of an SGLT2 Inhibitor in Preventing Painful Diabetic NeuropathyAndrea Cignarella, Cristina D Peterson
Cardiovascular Drugs and Therapy|December 31, 2003
Impact of statins on novel risk markersAndrea Cignarella, Chiara Bolego, Rodolfo Paoletti
Trends in Pharmacological Sciences|February 9, 2010
Emerging role of estrogen in the control of cardiometabolic diseaseAndrea Cignarella, Mario Kratz, Chiara Bolego
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Atherosclerosis|May 14, 2011
Targeting interleukin-1ß hampers atherosclerosis progression - is there great promise?Andrea Cignarella
Expert Opinion on Drug Discovery|March 14, 2013
Animal and cellular models for hypolipidemic drugsAndrea Cignarella
Current Atherosclerosis Reports|September 20, 2007
Increasingly selective pharmacologic targets in cardiovascular diseaseRodolfo Paoletti, Andrea Cignarella
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Mechanisms of estrogen protection in diabetes and metabolic diseaseAndrea Cignarella, Chiara Bolego
Current Atherosclerosis Reports|October 4, 2003
Can we stabilize unstable plaque?Rodolfo Paoletti, Andrea Cignarella
The Journal of Pharmacology and Experimental Therapeutics|July 12, 2025
FFAR1/GPR40 agonists: Are new players in type 2 diabetes management on the horizon?Andrea Cignarella, Samuel Tetteh-Quarshie
Cardiovascular & Hematological Agents in Medicinal Chemistry|June 2, 2010
Enhancing endothelial progenitor cell function through selective estrogen receptor modulation: a potential approach to cardiovascular risk reductionAndrea Cignarella, Gian Paolo Fadini
The Journal of Pharmacology and Experimental Therapeutics|July 18, 2024
Mechanistic Chronopharmacology: Preclinical Modeling of an SGLT2 Inhibitor in Preventing Painful Diabetic NeuropathyAndrea Cignarella, Cristina D Peterson
Cardiovascular Drugs and Therapy|December 31, 2003
Impact of statins on novel risk markersAndrea Cignarella, Chiara Bolego, Rodolfo Paoletti
Trends in Pharmacological Sciences|February 9, 2010
Emerging role of estrogen in the control of cardiometabolic diseaseAndrea Cignarella, Mario Kratz, Chiara Bolego
Pageof 8